Clinical Trial Update: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of two atypical antipsychotics versus placebo in acute exacerbations of schizophrenia or schizoaffective disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Atypical Antipsychotic 1
• Atypical Antipsychotic 2

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED